Bortezomib with Dexamethasone in Newly Diagnosed Patients with Primary Systemic Light Chain Amyloidosis or Multiple Myeloma-Associated AL Amyloidosis

被引：1
|
作者：
Huang, Beihui [1 ]
Li, Juan [1 ]
Liu, Junru [1 ]
Zheng, Dong [1 ]
Chen, Mei [1 ]
Zhou, Zhenhai [1 ]
Xu, Duorong [1 ]
Zou, Waiyi [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.5036.5036
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5036
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Systemic AL amyloidosis associated with multiple myeloma in a horse
    Kim, DY
    Taylor, HW
    Eades, SC
    Cho, DY
    VETERINARY PATHOLOGY, 2005, 42 (01) : 81 - 84
  • [32] Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis
    Lamm, W.
    Willenbacher, W.
    Lang, A.
    Zojer, N.
    Muelduer, E.
    Ludwig, H.
    Schauer-Stalzer, B.
    Zielinski, C. C.
    Drach, J.
    ANNALS OF HEMATOLOGY, 2011, 90 (02) : 201 - 206
  • [33] Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis
    W. Lamm
    W. Willenbacher
    A. Lang
    N. Zojer
    E. Müldür
    H. Ludwig
    B. Schauer-Stalzer
    C. C. Zielinski
    J. Drach
    Annals of Hematology, 2011, 90 : 201 - 206
  • [34] Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis
    Lamm, W.
    Willenbacher, W.
    Lang, A.
    Zojer, N.
    Muelduer, E.
    Ludwig, H.
    Zielinski, C. C.
    Drach, J.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 192 - 193
  • [35] PRIMARY AMYLOIDOSIS ASSOCIATED With Kappa Light Chain Myeloma
    Martins, Raquel G.
    Roncon-Albuquerque, Roberto, Jr.
    Cabral, Raquel
    Frazao, Joao
    Von Hafe, Pedro
    ACTA MEDICA PORTUGUESA, 2010, 23 (02): : 281 - 284
  • [36] A Case of Multiple Myeloma-Associated Systemic Amyloidosis with Multiple Skin Manifestations as the First Symptom
    Yao, Shunyu
    Wang, Suxia
    Yi, Runxi
    Ran, Liwei
    Zhang, Cang
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 987 - 993
  • [37] Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients with Myeloma or Systemic AL Amyloidosis: High Response Rates and Minimal Toxicity
    Shah, Gunjan L.
    Kaul, Esha
    Fallo, Shelly
    Cossor, Furha I.
    Smith, Hedy
    Klein, Andreas K.
    Miller, Kenneth B.
    Comenzo, Raymond L.
    BLOOD, 2012, 120 (21)
  • [38] Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
    Sidana, Surbhi
    Narkhede, Mayur
    Elson, Paul
    Hastings, Debbie
    Faiman, Beth
    Valent, Jason
    Samaras, Christy
    Hamilton, Kimberly
    Liu, Hien K.
    Smith, Mitchell R.
    Reu, Frederic J.
    PLOS ONE, 2017, 12 (03):
  • [39] Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis
    Kastritis, Efstathios
    Leleu, Xavier
    Arnulf, Bertrand
    Zamagni, Elena
    Cibeira, Maria Teresa
    Kwok, Fiona
    Mollee, Peter
    Hajek, Roman
    Moreau, Philippe
    Jaccard, Arnaud
    Schoenland, Stefan O.
    Filshie, Robin
    Nicolas-Virelizier, Emmanuelle
    Augustson, Bradley
    Mateos, Maria-Victoria
    Wechalekar, Ashutosh
    Hachulla, Eric
    Milani, Paolo
    Dimopoulos, Meletios A.
    Fermand, Jean-Paul
    Foli, Andrea
    Gavriatopoulou, Maria
    Klersy, Catherine
    Palumbo, Antonio
    Sonneveld, Pieter
    Johnsen, Hans Erik
    Merlini, Giampaolo
    Palladini, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (28) : 3252 - 3260
  • [40] Extensive Amyloid Purpura: An Unusual Presentation of Myeloma-associated Light Chain Amyloidosis
    Jaber, Nor Fazil
    Thelander, Ulrika
    Curman, Philip
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
12345